News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
HENNER DENNIS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2023 |
4
| HENNER DENNIS (Director) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Unknown transaction of 26,095 shares
@ $36, valued at
$939.4k
Disposed/sold 11,904 options to buy
@ $15.65, valued at
$186.3k
|
|
| 06/03/2022 |
4
| HENNER DENNIS (Director) has filed a Form 4 on Imago BioSciences, Inc.|
Txns:
| Granted 11,904 options to buy
@ $15.65, valued at
$186.3k
|
|
| 07/15/2021 |
3
| HENNER DENNIS (Director) has filed a Form 3 on Imago BioSciences, Inc. |
| 04/07/2020 |
4
| HENNER DENNIS (Director) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Disposed/sold 20,645 options to buy
@ $8.7575, valued at
$180.8k
Disposed/sold 10,322 options to buy
@ $10.81, valued at
$111.6k
|
|
| 06/14/2019 |
4
| HENNER DENNIS (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Granted 10,322 options to buy
@ $10.81, valued at
$111.6k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 07/02/2018 |
4
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Converted 938,489 shares
@ $0
Converted 755,780 shares
@ $0
Converted 1,922,682 shares
@ $0
Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0
Converted 755,780 preferred shares
@ $0
Converted 1,922,682 preferred shares
@ $0 |
|
| 07/02/2018 |
4
| HENNER DENNIS (10% Owner) has filed a Form 4 on Forty Seven, Inc.|
Txns:
| Converted 938,489 shares
@ $0
Converted 755,780 shares
@ $0
Converted 1,922,682 shares
@ $0
Bought 200,000 shares
@ $16, valued at
$3.2M
Converted 938,489 preferred shares
@ $0
Converted 755,780 preferred shares
@ $0
Converted 1,922,682 preferred shares
@ $0 |
|
| 06/27/2018 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Forty Seven, Inc. |
| 06/27/2018 |
3
| HENNER DENNIS (10% Owner) has filed a Form 3 on Forty Seven, Inc. |
| 10/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 103,123 shares
@ $0.19, valued at
$19.6k
Sold 230,507 shares
@ $0.16, valued at
$36.9k
|
|
| 02/09/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 02/05/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 82,583 shares
@ $0.15, valued at
$12.4k
Sold 500,026 shares
@ $0.14, valued at
$70k
Sold 832,881 shares
@ $0.2, valued at
$166.6k
|
|
| 02/02/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 52,826 shares
@ $0.26, valued at
$13.7k
Sold 140,000 shares
@ $0.2, valued at
$28k
Sold 176,306 shares
@ $0.17, valued at
$30k
|
|
| 01/28/2016 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on TETRALOGIC PHARMACEUTICALS CORP|
Txns:
| Sold 69,425 shares
@ $0.3, valued at
$20.8k
Sold 209,984 shares
@ $0.27, valued at
$56.7k
Sold 32,521 shares
@ $0.26, valued at
$8.5k
|
|
| 06/17/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 1,529 shares
@ $14.27, valued at
$21.8k
Sold 39,701 shares
@ $14.3, valued at
$567.7k
|
|
| 06/12/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 25,168 shares
@ $14.27, valued at
$359.1k
Sold 6,430 shares
@ $14.25, valued at
$91.6k
|
|
| 06/10/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 2,662 shares
@ $14.25, valued at
$37.9k
Sold 13,000 shares
@ $14.26, valued at
$185.4k
Sold 8,987 shares
@ $14.32, valued at
$128.7k
|
|
| 06/03/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 15,010 shares
@ $14.29, valued at
$214.5k
Sold 11,014 shares
@ $14.25, valued at
$156.9k
Sold 10,450 shares
@ $14.32, valued at
$149.6k
|
|
| 05/28/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on Ophthotech Corp.|
Txns:
| Disposed of 1,554,744 shares
@ $0 |
|
| 03/24/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 27,115 shares
@ $14.53, valued at
$394k
Sold 26,300 shares
@ $14.44, valued at
$379.8k
|
|
| 03/19/2015 |
4
| Clarus Lifesciences I, L.P. (10% Owner) has filed a Form 4 on Oxford Immunotec Global PLC|
Txns:
| Sold 79,307 shares
@ $14.67, valued at
$1.2M
Sold 25,000 shares
@ $14.68, valued at
$367k
Sold 50,012 shares
@ $14.61, valued at
$730.7k
|
|
| 01/30/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed of 3,139,447 shares
@ $0 |
|
| 01/30/2015 |
4/A
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 321,000 shares
@ $10, valued at
$3.2M
Converted 184,812 options to buy
@ $0.05, valued at
$9.2k
|
|
| 01/12/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 175,000 shares
@ $31.11, valued at
$5.4M
|
|
| 01/06/2015 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 13,420 shares
@ $30.67, valued at
$411.6k
Sold 10,200 shares
@ $31.11, valued at
$317.3k
|
|
| 12/30/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 74,510 shares
@ $30.05, valued at
$2.2M
Sold 6,214 shares
@ $30.03, valued at
$186.6k
|
|
| 12/24/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 49,441 shares
@ $30.36, valued at
$1.5M
Sold 263 shares
@ $30, valued at
$7.9k
|
|
| 06/16/2014 |
4
| Clarus Lifesciences II, L.P. (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 13,500 options to buy
@ $17.55, valued at
$236.9k
|
|
|
|
|